D
AZN icon

Diversified’s AstraZeneca AZN Stock Holding History

Diversified’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$331K Buy
2,125
+18
+0.9% +$2.91K 0.04% 164
2024
Q2 		$329K Buy
2,107
+187
+10% +$28.1K 0.04% 161
2024
Q1 		$260K Sell
1,920
-183
-9% -$24.2K 0.04% 138
2023
Q4 		$283K Sell
2,103
-112
-5% -$14.6K 0.06% 120
2023
Q3 		$300K Buy
2,215
+70
+3% +$9.56K 0.08% 103
2023
Q2 		$307K Sell
2,145
-31
-1% -$4.56K 0.08% 105
2023
Q1 		$302K Sell
2,176
-27
-1% -$3.63K 0.11% 108
2022
Q4 		$299K Buy
2,203
+161
+8% +$20.2K 0.12% 108
2022
Q3 		$224K Buy
2,042
+2
+0.1% +$254 0.11% 107
2022
Q2 		$270K Hold
2,040
– – 0.11% 85
2022
Q1 		$271K Buy
2,040
+69
+4% +$8.28K 0.11% 94
2021
Q4 		$230K Hold
1,971
– – 0.1% 103
2021
Q3 		$237K Buy
1,971
+8
+0.4% +$931 0.13% 95
2021
Q2 		$235K Buy
+1,963
New +$215K 0.13% 96
2021
Q1 		– Sell
-1,943
Closed -$213K – 111
2020
Q4 		$213K Buy
+1,943
New +$206K 0.18% 84

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Diversified's AZN Position: Q3 2024 in Review

Diversified increased its AstraZeneca (AZN) stake by 0.85% in Q3 2024, buying an estimated $2.91K and bringing the position to 2,125 shares worth $331K. The position accounts for 0.04% of the portfolio, ranked #164.

Diversified first reported a position in AZN in Q4 2020 and has held it in 15 quarters since. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

  • Diversified held 2,125 shares of AstraZeneca worth $331K as of Q3 2024.
  • Diversified bought 18 AstraZeneca shares in Q3 2024, an estimated $2.91K.
  • AstraZeneca made up 0.04% of Diversified's portfolio in Q3 2024, its #164 holding.
  • Diversified first reported a position in AstraZeneca in Q4 2020 and has held it in 15 quarters since.
  • 1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on Diversified's 13F filing for Q3 2024, filed 13 Nov 2024.